Independent · evidence-based · non-judgmentalDraft · pending medical review
Not yet medically reviewed — information on this site is in preparation and has not been verified by a medical reviewer.
Drug index / Cannabinoid / Cannabis / THC
Cannabinoid

Cannabis / THC

(6aR,10aR)-6,6,9-trimethyl-3-pentyl-6a,7,8,10a-tetrahydrobenzo[c]chromen-1-ol

Cannabis is a widely used plant drug whose main psychoactive compound is THC; risks include impairment, dependence, and — for some — anxiety or psychosis. Its U.S. legal status is in active flux.

Overview

Cannabis (marijuana) is a plant whose dried flowers and extracts are used for psychoactive and, in some cases, medical effects. Its principal psychoactive compound is delta-9-tetrahydrocannabinol (THC); it also contains cannabidiol (CBD) and many other cannabinoids. Cannabis is smoked or vaporized, or eaten in edibles, and the potency of today's products — especially concentrates and extracts — is substantially higher than in past decades. While often perceived as low-risk, cannabis can impair coordination, judgment, and memory, can lead to dependence, and can provoke anxiety, panic, or — in vulnerable individuals — psychosis. Its legal status is unusually complicated and currently changing, differing sharply between U.S. federal and state law and from one country to another.

Source: NIDA; PubChem CID 16078 (THC)

Chemistry & mechanism of action

THC acts by binding to cannabinoid receptors (chiefly CB1) that are part of the body's endocannabinoid system — a network helping regulate mood, appetite, memory, coordination, and the perception of pain and pleasure. By activating these receptors, THC alters the system's normal signaling, producing the characteristic changes in perception, mood, and cognition and influencing dopamine pathways tied to reward. The same receptor activity accounts for many of cannabis's effects and side effects, from altered time perception and appetite changes to impaired short-term memory and coordination. Higher-potency products deliver more THC, which can intensify both desired and adverse effects, particularly anxiety and, with heavy or frequent use, the risk of dependence.

Source: NIDA; PubChem CID 16078 (THC)

Effects

Short-term effects commonly include relaxation, altered perception of time and the senses, increased appetite, and talkativeness or giddiness, along with impaired short-term memory, attention, coordination, and reaction time. Less welcome short-term effects include anxiety, panic, paranoia, a racing heart, dizziness, dry mouth, and red eyes; very high doses — especially from edibles, whose delayed onset can lead people to take more — can cause intense anxiety, disorientation, nausea and vomiting, and temporary psychotic symptoms. Impaired coordination and judgment make driving while impaired a real hazard. With regular use, some people develop cannabis use disorder and experience withdrawal — irritability, sleep difficulty, decreased appetite, and craving — on stopping. Long-term, frequent use beginning in adolescence is associated with effects on learning and memory, and heavy use is linked, in vulnerable individuals, to an increased risk of psychotic disorders.

Source: NIDA

Risks & harms

The most common cannabis risks are impairment-related: slowed reaction time and impaired judgment make driving or operating machinery dangerous, and effects can be stronger and longer-lasting than expected — especially with edibles, where delayed onset often leads people to consume more before the first dose takes effect. Higher-potency concentrates raise the chance of acute anxiety, panic, and occasionally temporary psychotic reactions; people with a personal or family history of psychosis face elevated risk. Frequent use can lead to dependence, and cannabinoid hyperemesis syndrome — cycles of severe vomiting — can develop in some long-term heavy users. Cannabis is generally not associated with fatal overdose the way opioids are, but illicit or unregulated products can be contaminated (with other drugs, or harmful additives in some vaping products), and combining cannabis with alcohol or other substances increases impairment. Keeping cannabis products away from children, who can be seriously harmed by accidental ingestion of edibles, matters. For poisoning guidance call Poison Control at 1-800-222-1222; for substance-use support the SAMHSA National Helpline is 1-800-662-4357.

Source: NIDA; SAMHSA

Medicinal use

FDA-approved cannabis-derived products exist (e.g., Epidiolex; dronabinol/Marinol, Syndros)

History

placed in Schedule I in 1970

Images

Visual references coming soon.

If it’s too intense

If an experience becomes overwhelming, the goal is to stay safe and let it pass — most difficult experiences ease as the drug wears off.

  • Get to a calm, safe space with someone you trust who is sober and can stay with you.
  • Cool down if you’re overheating — move somewhere cool, remove extra layers, rest. Overheating is especially a risk with stimulants and MDMA.
  • Sip water to thirst — but don’t over-hydrate. Drinking large amounts of plain water (especially after MDMA) can dangerously dilute your blood sodium (hyponatremia). Electrolytes help more than volume.
  • Slow your breathing — long, slow exhales help settle a racing heart and anxiety.
  • A sugary drink, fruit juice, or a snack can ease shakiness and the anxiety that comes with low blood sugar.
  • Do not take more, and do not add another substance to manage it. Redosing or adding something else (including a sedative like a benzodiazepine) can make things worse, not better.

With cannabis, anxiety or a racing heart usually pass with time. Sit somewhere calm, sip water, and rest — strong edibles in particular can take hours to ease.

Call 911 (or Poison Control, 1-800-222-1222) right away for chest pain, a very high body temperature, a seizure, unconsciousness, or severe confusion. These are medical emergencies, not something to wait out.

Source: general harm-reduction guidance from SAMHSA, NIH/NIDA, and MedlinePlus, in our own words. Draft — not yet medically reviewed.

Forensic dossier

Draft · every field is source-cited or marked “Unknown — pending review”

Identity

IUPAC name
(6aR,10aR)-6,6,9-trimethyl-3-pentyl-6a,7,8,10a-tetrahydrobenzo[c]chromen-1-olPubChem PUG-REST · retrieved 2026-06-18
SMILES
CCCCCC1=CC(=C2[C@@H]3C=C(CC[C@H]3C(OC2=C1)(C)C)C)OPubChem PUG-REST · retrieved 2026-06-18
InChIKey
CYQFCXCEBYINGO-IAGOWNOFSA-NPubChem PUG-REST · retrieved 2026-06-18
Synonyms / aliases
weed, marijuana, thc, Dronabinol, TETRAHYDROCANNABINOL, Marinol, delta9-Tetrahydrocannabinol, delta9-THC, delta-9-tetrahydrocannabinol, Abbott 40566, delta1-THC, delta-9-THCPubChem PUG-REST + seed aliases · retrieved 2026-06-18

Composition

Composition
N/A — single compound (see Identity)

Physical / pill characteristics

Dosage form
Unknown — pending review (no Rx/OTC label; illicit — pill visuals = FIRST-PARTY submissions only, never generated or scraped)
Route
Unknown — pending review
Shape
Unknown — pending review
Color
Unknown — pending review
Imprint
Unknown — pending review
Score
Unknown — pending review

Scheduling & legal status

US schedule
Unknown — pending review
International
See EMCDDA/EUDA + WHO — synthesize per jurisdictionEMCDDA / EUDA · retrieved 2026-06-18

Effects

Effects
Cited source pending synthesis — author in our words from NIDA/MedlinePlus on review (NOT auto-generated)NIDA + MedlinePlus · retrieved 2026-06-18

Risks

Risks
Cited source pending synthesis — author in our words from NIDA/MedlinePlus on review (NOT auto-generated)NIDA + MedlinePlus · retrieved 2026-06-18

Interactions

Interactions
Unknown — pending review

Dosage

Pending medical reviewer

Sources

← Back to the drug index